HEMATOLOGIC MALIGNANCY
Clinical trials for HEMATOLOGIC MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC MALIGNANCY trials appear
Sign up with your email to follow new studies for HEMATOLOGIC MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Writing your way to wellness: new study explores expressive writing for blood cancer patients
Symptom relief OngoingThis study looks at whether an online expressive writing workshop can improve emotional wellness in young adults (ages 18-39) with blood cancer. About 100 participants will take part in a four-week writing program and complete surveys over 12 weeks. Researchers will compare their…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: NA • Sponsor: Blood Cancer United • Aim: Symptom relief
Last updated Apr 29, 2026 15:15 UTC
-
Can tablets help older cancer patients? new study finds out!
Knowledge-focused OngoingThis study looks at whether older adults with cancer (age 65+) can use computer surveys to report their health and daily living needs. Researchers tested two different computer methods to see which is easier and more reliable. The goal is to make it simpler for doctors to get imp…
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated May 01, 2026 15:23 UTC
-
Cancer tissue bank study seeks 1,200 volunteers to unlock new therapies
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects leftover tissue and blood samples from people with known or suspected cancer who are already scheduled for surgery or biopsy. Researchers will compare cancerous and normal tissues to find differences that could lead to new treatments. About 1,200 adults aged 1…
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:49 UTC
-
15-Year safety check for caribou cell therapy patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study watches over people who have already received Caribou cell therapy in earlier studies. The goal is to track any long-term side effects and safety issues for up to 15 years after treatment. About 150 participants with certain blood cancers will be followed without recei…
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: Caribou Biosciences, Inc. • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:13 UTC